Lake Forest, Ill.-based Omron Healthcare, which manufactures and distributes home healthcare products, led the funding round. Other participating organizations included Rochester, Minn.-based Mayo Clinic and existing inside investors. AliveCor will use the new funds to expand its heart health business.
AliveCor develops software to enable early detection and prevention of heart disease and stroke. It recently released its artificial intelligence-powered platform, called Kardia Pro, in the United States. Kardia Pro allows physicians to monitor patients for early detection of atrial fibrillation.
“Kardia Pro tracks important measures of physiology like weight, activity and blood pressure, and, for the first time, AI technology is used to create a personal heart profile for each user, enabling user identification,” said Vic Gundotra, CEO of AliveCor.
More articles on health IT:
IBM to launch new data services
Study: EHR vendors, health systems engage in information blocking
Health IT coalition voices support for Dr. John Fleming’s HHS appointment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
